Dana-Farber researchers report clinical trial results in treatment of leukemia & lymphoma

(Dana-Farber Cancer Institute) New results from clinical trials of immunotherapy and experimental targeted agents for patients with leukemia and lymphoma are being presented by Dana-Farber Cancer Institute researchers at the ASH Annual Meeting.